πŸ‡ΊπŸ‡Έ FDA
Patent

US 7470700

Dipeptidyl peptidase inhibitors

granted A61PA61P13/12A61P17/06

Quick answer

US patent 7470700 (Dipeptidyl peptidase inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Dec 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61P, A61P13/12, A61P17/06, A61P19/00, A61P19/02